KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Cash from Financing Activities: 2018-2024

Historic Cash from Financing Activities for Castle Biosciences (CSTL) over the last 7 years, with Dec 2024 value amounting to $6.1 million.

  • Castle Biosciences' Cash from Financing Activities fell 209.67% to -$919,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.8 million, marking a year-over-year decrease of 194.27%. This contributed to the annual value of $6.1 million for FY2024, which is 367.15% up from last year.
  • Latest data reveals that Castle Biosciences reported Cash from Financing Activities of $6.1 million as of FY2024, which was up 367.15% from -$2.3 million recorded in FY2023.
  • Castle Biosciences' Cash from Financing Activities' 5-year high stood at $305.9 million during FY2020, with a 5-year trough of -$2.3 million in FY2023.
  • Over the past 3 years, Castle Biosciences' median Cash from Financing Activities value was $1.5 million (recorded in 2022), while the average stood at $1.8 million.
  • As far as peak fluctuations go, Castle Biosciences' Cash from Financing Activities tumbled by 251.68% in 2023, and later surged by 367.15% in 2024.
  • Yearly analysis of 5 years shows Castle Biosciences' Cash from Financing Activities stood at $305.9 million in 2020, then plummeted by 98.23% to $5.4 million in 2021, then slumped by 72.05% to $1.5 million in 2022, then slumped by 251.68% to -$2.3 million in 2023, then skyrocketed by 367.15% to $6.1 million in 2024.